3-119557716-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_005191.4(CD80):c.13C>T(p.Arg5Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000149 in 1,611,814 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_005191.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CD80 | NM_005191.4 | c.13C>T | p.Arg5Trp | missense_variant | 2/7 | ENST00000264246.8 | NP_005182.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CD80 | ENST00000264246.8 | c.13C>T | p.Arg5Trp | missense_variant | 2/7 | 1 | NM_005191.4 | ENSP00000264246.3 | ||
CD80 | ENST00000478182.5 | c.13C>T | p.Arg5Trp | missense_variant | 2/6 | 1 | ENSP00000418364.1 | |||
CD80 | ENST00000383669.3 | c.13C>T | p.Arg5Trp | missense_variant | 1/4 | 1 | ENSP00000373165.3 | |||
CD80 | ENST00000463729.1 | n.125C>T | non_coding_transcript_exon_variant | 1/2 | 1 |
Frequencies
GnomAD3 genomes AF: 0.0000920 AC: 14AN: 152176Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000100 AC: 25AN: 249562Hom.: 0 AF XY: 0.000119 AC XY: 16AN XY: 134920
GnomAD4 exome AF: 0.000155 AC: 226AN: 1459638Hom.: 0 Cov.: 29 AF XY: 0.000150 AC XY: 109AN XY: 726118
GnomAD4 genome AF: 0.0000920 AC: 14AN: 152176Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74338
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 03, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at